GemVax&KAEL Co.,Ltd.

A082270

KR7082270000

Semiconductors

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-27 pm EDT			5-day change	1st Jan Change
11,090 ^KRW	+0.09%		-1.86%	-16.49%

May. 02	Gemvaxlink Co., Ltd. announced that it has received KRW 39.0999772 billion in funding from GemVax&KAEL Co.,Ltd., Keonyang Co., Ltd., Wingbridge I&D Co., Ltd., Kaffaint Co. Ltd	CI
Mar. 25	GemVax&KAEL Co.,Ltd. announced that it has received KRW 17.6 billion in funding from Kiwoom Asset Management Co., Ltd., J&J Assets Management Ltd., Youngjin Industry Co., Ltd. and other investors	CI

GemVax & Kael Co.,Ltd. agreed to acquire the remaining 3.86% stake in KAEL-GemVax Co., Ltd. for KRW 10.6 billion.

January 19, 2014

GemVax & Kael Co.,Ltd. (KOSDAQ:A082270) agreed to acquire the remaining 9.77% stake in KAEL-GemVax Co., Ltd. for KRW 10.6 billion in cash on January 20, 2014. GemVax & Kael will acquire remaining 0.66 million shares of KAEL-GemVax. Under the trems the partial payment will be received through issuance of KAEL-GemVax Co., Ltd.'s 5th unregistered unguaranteed convertible bonds for 4,177 million won on January 22, 2014, and the rest of the payment will be received in cash.

In an amendment GemVax & Kael Co., Ltd. will acquire 3.86% stake and 0.26 million shares. The transaction is expected to close by January 22, 2014.

Latest news about GemVax&KAEL Co.,Ltd.

Gemvaxlink Co., Ltd. announced that it has received KRW 39.0999772 billion in funding from GemVax&KAEL Co.,Ltd., Keonyang Co., Ltd., Wingbridge I&D Co., Ltd., Kaffaint Co. Ltd	May. 01	CI
GemVax&KAEL Co.,Ltd. announced that it has received KRW 17.6 billion in funding from Kiwoom Asset Management Co., Ltd., J&J Assets Management Ltd., Youngjin Industry Co., Ltd. and other investors	Mar. 24	CI
GemVax&KAEL Co.,Ltd. announced that it expects to receive KRW 17.6 billion in funding from Kiwoom Asset Management Co., Ltd., J&J Assets Management Ltd., Youngjin Industry Co., Ltd. and other investors	Mar. 20	CI
Gemvaxlink Co., Ltd. announced that it has received KRW 29.099978456 billion in funding from GemVax&KAEL Co.,Ltd., Keonyang Co., Ltd., Wingbridge I&D Co., Ltd., Kaffaint Co. Ltd and other investors	Mar. 17	CI
Tranche Update on GemVax&KAEL Co.,Ltd's Equity Buyback Plan announced on June 14, 2022.	22-08-31	CI
GemVax&KAEL Co.,Ltd announces an Equity Buyback for 150,000 shares.	22-06-13	CI
GemVax&KAEL Co.,Ltd authorizes a Buyback Plan.	22-06-13	CI
Tranche Update on GemVax&KAEL Co.,Ltd's Equity Buyback Plan announced on April 13, 2022.	22-06-13	CI
GemVax&KAEL Co.,Ltd's Equity Buyback announced on April 13, 2022, has closed with 300,000 shares, representing 0.76% for KRW 4,333.75 million.	22-06-09	CI
GemVax&KAEL Co.,Ltd announces an Equity Buyback for 300,000 shares.	22-04-13	CI
GemVax&KAEL Co.,Ltd authorizes a Buyback Plan.	22-04-12	CI
GemVax&KAEL Co.,Ltd(KOSDAQ:A082270) added to S&P Global BMI Index	21-09-20	CI
GemVax&KAEL Co.,Ltd acquired additional 12.9% stake in Gemvaxlink Co., Ltd. for KRW 18 billion.	21-08-18	CI
GemVax&KAEL Co.,Ltd acquired additional 12.99% stake in Gemvaxzio Co., Ltd. for KRW 18.02 billion.	21-08-18	CI
GemVax's Highly Promising Phase II Alzheimer's Disease Clinical Trial Results Targeting Telomerase Published in Alzheimer's Research & Therapy' Journal	21-03-30	CI
GemVax&KAEL Co.,Ltd(KOSDAQ:A082270) dropped from S&P Global BMI Index	21-03-22	CI
GemVax & KAEL Announces the Decision to Apply for an Expanded Access IND for Its Lead Candidate GV1001 to Include Additional Investigational Groups in Alzheimer's	20-10-06	CI
Gemvaxzio Co., Ltd. announced that it has received KRW 3.49999944 billion in funding from GemVax&KAEL Co.,Ltd	20-06-17	CI
Gemvaxzio Co., Ltd. announced that it expects to receive KRW 3.49999944 billion in funding from GemVax&KAEL Co.,Ltd	20-06-09	CI
Gemvaxzio Co., Ltd. announced that it has received KRW 4.999999927 billion in funding from GemVax&KAEL Co.,Ltd	20-04-15	CI
Gemvaxzio Co., Ltd. announced that it expects to receive KRW 4.999999927 billion in funding from GemVax&KAEL Co.,Ltd	20-04-07	CI
Gemvaxzio Co., Ltd. announced that it has received KRW 8.4 billion in funding from GemVax&KAEL Co.,Ltd	20-03-29	CI
GemVax Announces Phase II Results of GV1001 for Alzheimer's Disease Treatment at CTAD 2019	19-12-11	CI
Enerzent Co., Ltd. announced that it has received KRW 10 billion in funding from GemVax&KAEL Co.,Ltd	19-02-10	CI
GemVax&KAEL Co.,Ltd announced that it has received KRW 35 billion in funding	18-08-09	CI

Chart GemVax&KAEL Co.,Ltd.

Duration

Period

More charts

Company Profile

GemVax & KAEL Co.,Ltd is a Korea-based company mainly engaged in the manufacture of pollution control equipment used in semiconductor manufacturing processes. The Company and its subsidiaries are engaged in the three categories of businesses: pollution control business, which manufactures chemical air (CA) filters, gas scrubbers, resins, coating resins and other environmental equipments and systems; anticancer and anti-inflammation business, which engages in development of cancer vaccines for infectious diseases, such as acquired immune deficiency syndrome (AIDS) and anti-inflammations, and IT business which mainly produces liquid crystal display (LCD) modules. The Company distributes its products within domestic market and to overseas markets.

Sector

Semiconductors

More about the company

Income Statement Evolution

More financial data

Sector Other Semiconductors

	1st Jan change	Capi.
GEMVAX&KAEL CO.,LTD.	-16.49%	322M
NVIDIA CORPORATION	+130.32%	2,802B
TSMC (TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY)	+45.87%	697B
BROADCOM INC.	+26.54%	655B
AMD (ADVANCED MICRO DEVICES)	+16.42%	277B
QUALCOMM, INC.	+47.33%	238B
TEXAS INSTRUMENTS INCORPORATED	+17.09%	182B
MICRON TECHNOLOGY, INC.	+55.46%	147B
ARM HOLDINGS PLC	+66.27%	130B
ANALOG DEVICES, INC.	+17.57%	116B